Arsanis Nominates Preclinical Candidate for Staphylococcus aureus Program PipelineReview.com (press release) VIENNA, Austria I May 23, 2013 I Arsanis Biosciences GmbH, a biotechnology company developing anti-infective human monoclonal antibodies, achieved a major milestone by nominating the preclinical development candidates for its lead program, ... |
